Guillain-Barré Syndrome

Area of Science:

• Neurology
• Immunology
• Pathogenesis of Neuromuscular Disorders

Background:

• Guillain-Barré syndrome (GBS) is a critical global neuromuscular emergency.
• It presents as an acute, inflammatory, immune-mediated polyradiculoneuropathy with diverse clinical and pathological presentations.
• Despite current treatments, a significant portion of GBS patients face poor prognoses and persistent neurological deficits.

Purpose of the Study:

• To provide a comprehensive summary of Guillain-Barré syndrome (GBS).
• To review clinical features, diagnostic criteria, differential diagnoses, pathogenesis, and prognosis.
• To discuss current and future diagnostic and therapeutic strategies for GBS.

Main Methods:

• Review of clinical features and diagnostic criteria for GBS.
• Analysis of pathogenic mechanisms, including molecular mimicry and ganglioside targets.
• Examination of electrodiagnostic findings (axonal, demyelinating, mixed).

Main Results:

• GBS exhibits varied subtypes influenced by antecedent infections and antibody responses.
• The International GBS Outcome Study offers validated prognosis tools and highlights regional differences.
• Emerging research focuses on novel biomarkers for diagnosis and potential new therapies.

Conclusions:

• GBS requires continued research into its complex pathogenesis.
• Development of new diagnostic biomarkers and targeted therapies is crucial.
• Improving outcomes for GBS patients necessitates a deeper understanding and advanced treatment approaches.